AJP - Heart and Circulatory Physiology, Vol 272, Issue 6 2547-H2556, Copyright © 1997 by American Physiological Society

ARTICLES

Pial arteriolar constriction to alpha 2-adrenergic agonist dexmedetomidine in the rat

Y. Asano, R. C. Koehler, T. Kawaguchi and R. W. McPherson
Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287-4961, USA.

Dexmedetomidine (Dex) is an alpha 2-adrenergic agonist that decreases cerebral blood flow (CBF) when administered systemically. It is unclear whether cerebral vasoconstriction is mediated by a local effect on cerebral vessels or by a remote neural mechanism. In the present study, we compared the pial arteriole responses to locally and systemically administered Dex with and without local application of the specific alpha 2-adrenergic antagonist atipamezole. Six groups of male rats (n = 7 each) were anesthetized with isoflurane and prepared for measurements of small (20-39 microns), medium (40-59 microns), and large (60-79 microns) pial arteriole diameter by intravital microscopy or for regional CBF measurement by the radiolabeled-microsphere method. Local application of Dex caused dose-dependent constriction that was significant starting at 10(-8) M for small and medium-sized arterioles and at 10(-7) M for large arterioles. Constriction to 10(-5) M in small [21 +/- 2% (SE)], medium (21 +/- 2%), and large (15 +/- 1%) arterioles was almost completely blocked by local application of 10(-4) M atipamezole. Intravenous administration of Dex at 1 microgram/kg decreased CBF and caused modest arteriolar constriction that began to resolve 8 min after administration. A dose of 10 micrograms/kg constricted arterioles of all sizes with constriction beginning to resolve after approximately 10 min. Local application of atipamezole (10(-4) M) slightly blunted the response to 1 micrograms/kg of intravenous Dex but did not substantially limit constriction after 10 micrograms/kg. These data demonstrate that pial arterioles are capable of substantial constriction to Dex by a local alpha 2-adrenergic mechanism. However, the inability of locally applied atipamezole to substantially inhibit the vasoconstrictor response to systemically administered Dex suggests that Dex might also cause vasoconstriction indirectly through actions at other sites in the central nervous system.

This article has been cited by other articles:

				H. Ohata, S. Cao, and R. C. Koehler Contribution of adenosine A2A and A2B receptors and heme oxygenase to AMPA-induced dilation of pial arterioles in rats Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2006; 291(3): R728 - R735. [Abstract] [Full Text] [PDF]

				X. Qin, H. Kwansa, E. Bucci, R. J. Roman, and R. C. Koehler Role of 20-HETE in the pial arteriolar constrictor response to decreased hematocrit after exchange transfusion of cell-free polymeric hemoglobin J Appl Physiol, January 1, 2006; 100(1): 336 - 342. [Abstract] [Full Text] [PDF]

				J. M. Bishai, L. Penninga, R. Nijland, R. Meulenaar, C. P. Gheorghe, Y. Zhao, J. N. Buchholz, L. Zhang, and L. D. Longo Pre- and postjunctional alpha 2-adrenergic receptors in fetal and adult ovine cerebral arteries Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2002; 282(6): R1654 - R1662. [Abstract] [Full Text] [PDF]

				H. Ohata, H. Iida, S. Dohi, and Y. Watanabe Intravenous Dexmedetomidine Inhibits Cerebrovascular Dilation Induced by Isoflurane and Sevoflurane in Dogs Anesth. Analg., August 1, 1999; 89(2): 370 - 370. [Abstract] [Full Text] [PDF]